North American Biodefense Market revenue to reach $10.2 Bn by 2028

Published Date: 2022-05-17

Request a sample

North American Biodefense Market size is poised to cross USD 10.2 billion by 2028, according to a latest forecast report by Graphical Research.

Several companies are focusing on their research and developmental activities for the adaptation of novel technologies in the market. Firms are focusing on manufacturing as well as producing biothreat detection systems for the identification of bacteria and viruses. The accessibility of improved biothreat detection technologies safeguards the population’s security and safety, thereby proving beneficial for the business progress. In addition, these technologies provide an anticipation to scientists, policymakers, and security personnel to possess reliable, effective biothreat detection device for defense applications. Moreover, amid pandemic the biodefense industry is anticipated to witness upsurge in discoveries and inventions.

The biothreat detection devices segment accounted for USD 2.1 Bn revenue in 2021, owing to extensive availability of biothreat detection devices to ensure safety as well as security of the population along with surging demand for identifiers. Identifier detects various common biothreat agents including anthrax, smallpox, ricin, black plague, botulinum toxin and tularemia. Identifier is a device that detect biological agent with highest accuracy and has also been proven to detect airborne SARS-CoV-2.  

Browse detailed statistical insights from the report, “North America Biodefense Market Forecast 2028 By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @

The Canada biodefense industry will surpass 8.5% CAGR during the analysis period. Presence of well-known healthcare firms will positively promote country’s market progress. Surging adoption of technological advanced product along with increasing awareness regarding biodefense among large number of population base in Canada will foster the country-level growth. Additionally, government is focusing on preventing and responding to an emergency or disaster and mainly concentrate on developing and maintaining national emergency response plan such as National Smallpox Contingency plan. Hence, various above-mentioned aspects fosters the market growth.  

The biodefense in North American market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:

North America Market, By Product

  • Vaccines
    • Anthrax
    • Smallpox
    • Botulism
  • Biothreat detection devices
    • Samplers
    • Detectors/Triggering devices
    • Identifiers
    • Assays & Reagents

The above information has been provided for the following countries:

  • North America
    • U.S.
    • Canada